― 289 ―Day 1: October 15, 2023 (Sunday)4:00 – 4:20pm Welcome and opening remarks4:20 – 7:15pm Opening Session 1: Celebrating the discovery of MDM2 and its functions7:45 – 9:45pm Welcome Party at SCHMATZ (https://www.schmatz.jp/)Day 2: October 16, 2023 (Monday)8:30 – 8:40am Welcome remarks8:40 – 9:15am Carol Prives (Keynote talk)9:15 – 10:35am Session 2: Novel function and regulation of MDM2/MDM4/p53 (part 1)10:35 – 11:05am COFFEE BREAK – Lobby11:05 – 12:10pm Session 3: p53-independent functions of MDM2/MDM412:10 – 2:10pm LUNCH & Poster (1:00-2:00pm)Special sessions: Cancer Immunology2:10 – 2:50pm Tadatsugu Taniguchi (Keynote talk)2:50 – 4:05pm Session 4: MDM2/MDM4/p53 in immunity and tumor immunity4:05 – 4:35pm COFFEE BREAK – Lobby4:35 – 6:20pm Session 5: MDM2/MDM4/p53 in tumor immunity and microenvironments, and Day 3: October 17, 2023 (Tuesday)8:30 – 9:05am S18: Sir. David Lane (Keynote talk)9:05 – 10:25am Session 6: Animal models of MDM2/MDM4/p5310:25 – 10:55am COFFEE BREAK – Lobby10:55 – 12:15pm Session 7: Novel function and regulation of MDM2/MDM4/p53 (part 2)12:15 – 2:15pm LUNCH & Poster (1:00-2:00pm)2:15 – 3:45pm Session 8: Controls of p53 signaling by MDM2/MDM4 and other ubiquitin ligases3:45 – 4:15pm BREAK & Discussion – Lobby4:15 – 5:45pm Session 9: Functions of p53, mutant p53, p53 family, and p53 isoforms7:30 – 9:30pm WORKSHOP DINNER at Berth One Tokyo (http://www.berth1.tokyo)Day 4: October 18, 2023 (Wednesday)8:30 – 9:45am Session 10: Development of therapies targeting MDM2/MDM4/p53 (part1)9:45 – 10:10pm BREAK & Discussion – Lobby10:10 – 11:20am Session 11: Development of therapies targeting MDM2/MDM4/p53 (part 2)11:20 – 12:05pm Arnold Levine (Final Remarks)12:05 – 1:20pm: Optional Conference Tour1:20pm dispatch / 1:30pm departure National Cancer Center (Tsukiji)˜7:00pm Return to National Cancer Center (Tsukiji)immunotherapyBoxed LUNCH and Departure/Optional tour
元のページ ../index.html#291